STERIS Cash Flow from Financial Activities 2010-2025 | STE
STERIS annual/quarterly cash flow from financial activities history and growth rate from 2010 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
- STERIS cash flow from financial activities for the quarter ending March 31, 2025 was $-1.572B, a 1745.8% increase year-over-year.
- STERIS cash flow from financial activities for the twelve months ending March 31, 2025 was $-5.145B, a 31595.9% decline year-over-year.
- STERIS annual cash flow from financial activities for 2025 was $-1.572B, a 1745.8% increase from 2024.
- STERIS annual cash flow from financial activities for 2024 was $-0.085B, a 82.92% decline from 2023.
- STERIS annual cash flow from financial activities for 2023 was $-0.499B, a 530.56% decline from 2022.
| STERIS Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2025 | $-1,572 |
| 2024 | $-85 |
| 2023 | $-499 |
| 2022 | $116 |
| 2021 | $346 |
| 2020 | $-163 |
| 2019 | $-295 |
| 2018 | $-356 |
| 2017 | $-267 |
| 2016 | $560 |
| 2015 | $70 |
| 2014 | $-54 |
| 2013 | $254 |
| 2012 | $-88 |
| 2011 | $-48 |
| 2010 | $-128 |
| 2009 | $-28 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $22.284B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $183.069B | 22.15 |
| Intuitive Surgical (ISRG) | United States | $177.069B | 73.39 |
| Edwards Lifesciences (EW) | United States | $46.042B | 30.54 |
| IDEXX Laboratories (IDXX) | United States | $45.559B | 52.36 |
| Alcon (ALC) | Switzerland | $44.466B | 30.05 |
| DexCom (DXCM) | United States | $35.105B | 54.26 |
| IQVIA Holdings (IQV) | United States | $33.619B | 19.00 |
| Mettler-Toledo (MTD) | United States | $26.208B | 31.17 |
| Waters (WAT) | United States | $17.993B | 25.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.253B | 0.00 |
| Hologic (HOLX) | United States | $14.639B | 15.91 |
| Sysmex ADR (SSMXY) | Japan | $10.588B | 30.04 |
| Penumbra (PEN) | United States | $8.914B | 69.96 |
| Masimo (MASI) | United States | $8.793B | 32.44 |
| Globus Medical (GMED) | United States | $7.351B | 17.52 |
| Glaukos (GKOS) | United States | $5.424B | 0.00 |
| Teleflex (TFX) | United States | $5.106B | 8.43 |
| Integer Holdings (ITGR) | United States | $3.789B | 18.91 |
| TransMedics (TMDX) | United States | $3.560B | 77.38 |
| PROCEPT BioRobotics (PRCT) | United States | $2.992B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.370B | 14.11 |
| Veracyte (VCYT) | United States | $1.959B | 27.50 |
| Elekta AB (EKTAY) | Sweden | $1.933B | 17.38 |
| Nihon Kohden (NHNKY) | Japan | $1.911B | 21.92 |
| Alphatec Holdings (ATEC) | United States | $1.636B | 0.00 |
| Artivion (AORT) | United States | $1.337B | 125.24 |
| Tandem Diabetes Care (TNDM) | United States | $1.122B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.018B | 5.41 |
| SiBone (SIBN) | United States | $0.750B | 0.00 |
| IRadimed (IRMD) | United States | $0.726B | 36.85 |
| Beta Bionics (BBNX) | United States | $0.607B | 0.00 |
| AxoGen (AXGN) | United States | $0.592B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.555B | 8.64 |
| OrthoPediatrics (KIDS) | United States | $0.544B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.541B | 11.65 |
| Pacific Biosciences Of California (PACB) | United States | $0.492B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.447B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.425B | 9.88 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.371B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.362B | 0.00 |
| RxSight (RXST) | United States | $0.320B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| Neuronetics (STIM) | United States | $0.299B | 0.00 |
| NeuroPace (NPCE) | United States | $0.287B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.254B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.245B | 14.82 |
| CVRx (CVRX) | United States | $0.220B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.182B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.155B | 0.00 |
| Accuray (ARAY) | United States | $0.143B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.125B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.121B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.106B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.091B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 53.20 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.070B | 0.00 |
| Positron (POSC) | United States | $0.061B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| WORK Medical Technology Group (WOK) | China | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.76 |